ArticleBritish journal of cancer2023

The novel CDK9 inhibitor, XPW1, alone and in combination with BRD4 inhibitor JQ1, for the treatment of clear cell renal cell carcinoma.

Zhijian Kuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.